Amtech Systems Inc (ASYS) 2012 Q2 法說會逐字稿

Good day, and welcome to the Amtech Systems Fiscal 2012 Second Quarter Results Conference Call. (Operator Instructions) I would now like to turn the conference over to Brad Anderson, Chief Financial Officer. Please go ahead.

Good afternoon, and thank you for joining us for Amtech Systems Second Quarter Fiscal 2012 Results Conference Call. On the call today are JS Whang, Amtech's Executive Chairman, Fokko Pentinga, our Chief Executive Officer and President, and myself, Brad Anderson, Chief Financial Officer.

After the close of market's trading today, Amtech released its 2012 financial results for the quarter ending March 31, 2012. The release will be posted on the Company's website at AmtechSystems.com.

During today's call, Management will make forward-looking statements. All such forward-looking statements are based on information available to us as of this date, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance, and actual results could differ materially from current expectations.

Among the important factors which could cause actual results to differ materially from those in the forward-looking statements, are changes in the technologies used by our customers and competitors; change in volatility and the demand for its products; the effect of changing worldwide political and economic conditions on government funded solar initiatives, capital expenditures, production levels, including those in Europe and Asia; the effect of overall market conditions, including the equity and credit markets and market acceptance risks. Other risk factors are detailed in the Company's Securities & Exchange Commission filings, including its Form 10-K and Form 10-Q.

Let me quickly highlight the agenda for this discussion. JS Whang, our Executive Chairman will first discuss our long term strategies and highlight what we see in the marketplace as we evaluate growth opportunities. Fokko Pentinga, our Chief Executive Officer, will update you on the current market, how we are addressing the challenging market, and discuss the progress in our technology and product development roadmap. I will then discuss second quarter financial results, year-over-year sequential trends, and our outlook for the June quarter.

So I will now turn the call over to JS Whang, our Executive Chairman to begin the discussion.

Thank you, Brad. Good afternoon, everyone. Thank you for joining us today. We really appreciate your interest in Amtech Systems. As we have said before, our long term objective is to continue to be a market leader by offering highly cost effective, leading edge technology solutions to current and prospective customers in the solar, semiconductor, and LED market, plus importantly, to expand our offerings in those markets and further diversify our future revenue stream.

At the beginning of this year, we announced my Executive Chairman role, and appointment of Fokko Pentinga to our CEO. I am pleased to report that as we planned for, this transfer of leadership to Fokko has been a very smooth transition for the entire global operations. The result is that I am now dedicating more of my time to investigating new opportunities for the Company. The focus is on opportunities for increasing our total available markets. Our Board and Management have a solid plan for long term success. We have well defined objectives that are understood across our global organizations. We continue to work each day for tomorrow and beyond and we are investing in our future and will continue to do so.

As we explore our market opportunities, our objective is to diligently pursue strategic acquisitions to expand the size of the market we serve, diversify our end market mix, and reduce our exposure to any single market. The ultimate objective will be to moderate the cyclicality in our business and better position the Company to realize more consistent growth through cycles in the future.

We see interesting strategic opportunities in solar, as well as in the semiconductor and energy markets.

Let me now discuss our acquisition growth plan. Although I cannot specifically detail our pipeline, our goal is not just the growth, but to add the right assets - solar and non-solar - that can deliver highly meaningful returns with very manageable risks. There are clearly objective opportunities in the marketplace and the pricing environment for acquisitions has become more manageable. In summary, I too--I want to assure you that our [diligent] process, the risk return analogies that we do, is a conservative approach as demonstrated in our previous cases.

At this time, let me specifically talk about solar as a long term opportunity and global need. Macroeconomic challenges across the globe and overcapacity continue to put pressure on the solar industry today, but we believe there is a significant worldwide commitment to expanding the solar energy and we make progress toward [global] based great parity. In solar, our objective is to continue to focus on next generation technologies that can support our customers' goals to enable higher efficiency at lower total cost of ownership.

Over our many years, we have proven that Amtech is a strong participant in marketplace, can deliver financially, can grow organically, and through successful acquisition of good business, technologies, and talent. We will continue this strength today and tomorrow and best position the Company to deliver value to all stakeholders over time. Let me now turn the call over to Fokko Pentinga, CEO, to discuss current operation and technologies in development. Fokko?

Thank you, JS. In the second quarter we continued to operate in a very difficult low demand marketplace. We maintained the highest level of service in our streamlined organization. We have restructured the manufacturing operations to best align cost [risk earned] and near term low demand. We have reduced our total headcount by almost 30% while at the same time increasing our ion implant operations in China and our semiconductor operations. Within our solar divisions, we have reduced headcounts by over 40%. We have and will continue to address all this (inaudible - accented) expenditure to minimize any potential excess in any part of our global operations. I want to emphasize though that we plan to maintain the expert talent needed in all core functional areas. We are well positioned to successfully manage through this period. Plus, our core is strong, and I believe our current structure is scalable both up and down, so when the opportunity arises to deliver into higher levels of demand, we are ready to.

Bookings were up modestly in the quarter, relative to our first quarter. However, the improvement, as Brad will detail later on, was not indicative for an upturn in the solar market overall. Important is that we hold our strategy course and continue to invest in our research and product development activities through the slower sales environment.

Let me now address some of the key development programs. First, our solar ion implants. We are developing a solar ion implant to provide our customers with a more complete solution for the next generation high efficiency solar cell production, and as a possible upgrade to their existing solar cell manufacturing lines. We continue to be encouraged by the positive feedback from selective potential customers. Next week at the Shanghai Solar show, we will unveil our ion implant system. We are excited about the value that this offering will bring to the next generation high efficiency solar marketplace. This ion implant system was developed from ground up in little more than one year, and is specifically developed to serve the needs of the solar industry.

On N-type, further developments for N-type technology is continuing for future high efficiency cells together with our technology partners. We have seen increased interest from the market in this technology, and see potential for projects to mature in the late part of this year. In other programs, at the Shanghai show next week, we will also introduce the tube-type batch PECVD system from Tempress. The development was based on the experience and expertise with diffusion batch processing and PECVD developments over the years, and the system will double the size of the market we serve.

Now on the market situation, there are many publications with different opinions about the market. What we see at the moment is that the solar market does not yet show an improvement for equipment sales for solar production expansion. At the same time, we do see increased interest for our new products and technologies like ion implant and N-type technology.

The semiconductor market has been strong and we are seeing good growth in the first two quarters and expect this to continue in the next two quarters. And before I turn the call over to Brad, let me summarize a few points. We will stay on course with our strategy developing the products needed in this new marketplace, and the introduction of the two new products and actually shows that we are on track with this. At the same time, we will continue to adjust our cost structure and create the right balance in order to continue our R&D and size the operations to market demand with the capability to ramp up when the solar market improves. We are very positive about our long term growth opportunity and expect to emerge from this down cycle as an even stronger company in our selective markets.

Now, I'd like to turn it over to Brad for the financials.

Thanks, Fokko. Let's review our second quarter results. Net revenue for the second quarter of fiscal 2012 was $21.6 million, down 13% sequentially from $24.7 million for the preceding quarter, and down 65% from the second quarter of fiscal 2011. The decrease was in line with our expectations and was driven by lower system shipments to customers in the solar industry. We were encouraged by our semiconductor revenue for the quarter, which totaled $11 million, a 36% increase from last year's quarter, and a 21% increase sequentially.

Total orders in the second quarter of fiscal 2012 were $18 million, $7.2 million of which were solar. This is up 62% compared to total orders of $11.1 million in the preceding quarter. At March 31, 2012, our order backlog was $67.4 million, compared to total backlog of $69.2 million at December 31, 2011. Solar backlog at March 31, 2012 was $54 million, compared to a solar backlog of $55.8 million at December 31, 2011. The effect of foreign exchange on backlog was a positive $1.8 million in the March quarter. Backlog includes deferred revenue and customer orders that are expected to ship within the next 12 months.

Gross margin in the second quarter of fiscal 2012 was 19%, compared to 29% sequentially and 40% in the second quarter of 2011. The lower gross margin is primarily due to lower sales volumes, resulting less efficient capacity utilization, and a write-down of inventory. Also, our net recognition of previously deferred revenue was lower in the second quarter compared to the first quarter.

Looking at our SG&A expenses, in the first quarter of fiscal 2012, were $6 million in the second--in this quarter $6 million, compared to $6.3 million in the preceding quarter, and $11.2 million in the second quarter a year ago. The decrease in our SG&A expense as compared to the second quarter of fiscal 2011 was primarily due to lower commissions and shipping costs associated with lower volumes, and also reflected corporate wide cost control initiatives.

We recorded an impairment charge of $688,000 in the second quarter, due to the write-down of certain licenses and related assets associated with our PSG removal tool and our previous in-line PECVD tool. R&D expense was $3.3 million in the second quarter of 2012, compared to $2.8 million in the preceding quarter, and $900,000 in the second quarter of fiscal 2011.

The year-over-year quarterly change is primarily due to investment in our solar ion implant project and development costs associated with other products and technology development programs, of which Fokko spoke to.

Depreciation and amortization in the second quarter of fiscal 2012 was $760,000, compared to $769,000 in the first quarter of fiscal 2012. Included in the second quarter of fiscal 2012 results is $437,000 of stock option expense, compared to $369,000 in the second quarter a year ago, and $465,000 in the first quarter of fiscal 2012.

The income tax benefit in the second quarter of 2012 was $220,000, resulting in an effective tax rate of approximately 4%. The net loss for the second quarter of fiscal 2012 was $5.1 million, or a loss of $0.54 per share, compared to a net loss of $900,000, or $0.09 per diluted share in the preceding quarter. Total revenue by geographic region for the fiscal second quarter was in the Asia Pacific region at 70%, Europe at 23%, and North America at 7%.

We continue to maintain a solid financial position with essentially no debt and total cash and cash equivalents of $48.8 million at March 31, 2012, compared to $54.9 million at December 31, 2011. The decrease in cash is primarily due to payments to vendors and excess receipts from our customers. At March 31, 2012, we had working capital of approximately $86.4 million. We will continue to manage our operations to maintain our solid financial position.

We continue to be focused on reducing our purchase commitments and managing inventory to an appropriate level. During the first six months of our fiscal year, we have reduced our purchase commitments by over $24 million.

Now, let me turn to our outlook. The supply-demand imbalance for solar cells and modules continue to negatively impact the entire solar value chain. As a result, the Company expects revenues in its fiscal 2012 third quarter, ending June 30, 2012, to be in the range of $18 million to $20 million. Gross margins are expected to be in line with or slightly higher than the second quarter of fiscal 2012. Research and development expenses are expected to be significantly higher in the June quarter, compared to the March quarter, primarily due to the build of the Beta version of our solar ion implant system. As a result, Amtech expects to incur a net loss in the third quarter.

As a reminder, our operating results could be impacted by the timing of system shipments, the net impact of revenue deferral on those shipments, and the recognition of revenue based on customer acceptances, all of which have in the past and can in the future have a significant effect on operating results. In addition, a substantial portion of our revenues is denominated in euros. The revenue outlook we have provided is based on an assumed exchange rate between the United States dollar and the euro. A significant decrease in the value of the euro in relation to the U.S. dollar could cause our revenues to be lower than anticipated.

This concludes the prepared remarks section of our conference call. Operator, please open the call to questions.

(Operator Instructions) The first question comes from Colin Rusch of ThinkEquity. Please go ahead.

Thanks, guys, and congrats on getting the products ready to get out to the market. Can you talk a little bit about your expectations for how long you'll have those initial products out testing with customers before you begin to see orders?

I assume you talk about specifically the ion implant, but it's--the time needed for machines to get full acceptance, meaning in production and expectation is that at least it will take six months' time before you fully qualify machines in a production environment. And that counts for most products. PECVD can be a little bit shorter, but also there, there is a certain time needed. So that's the timeframe you're looking at.

Perfect. And then, on the order backlog, can you breakout how much of the solar orders are deferred revenue and how much are actual shipments that are yet to come?

Yes, I don't have that number in front of me, but I can get that to you offline.

Okay, thanks a lot. And then, just the last one on the R&D spend. When do you think you'll start to see that higher R&D spend start to wind down a bit?

A lot of that depends on timing of--as I mentioned in the prepared remarks, we expect it to be higher because of the Beta tool. And we may--depending on whether we build another Beta tool and where we're at from a technology development, we actually are right now expensing all material costs related to both the prototype, the alpha, and the two Beta tools that are--we're in the process of starting to build. So you--as we mentioned, the June quarter is going to be higher. Could be up at that--in the September quarter? Maybe. Our expectation is within a quarter or two we should be able to be back down to a lower level.

Perfect. Thanks a lot, guys. I'll hop back in the queue.

Thanks, Colin.

The next question comes from Jeff Osborne of Stifel Nicolaus. Please go ahead.

Thank you. Fokko, I was wondering if maybe you could just give us the high points on the PECVD tool. And what do you think the advantages are versus the current incumbent that dominates the space?

The PECVD tool--and this is the batch, the tube-type batch tool, which is comparable to some other big companies who provide this type of equipment. And first of all, compared to the in-line tools on average we see that it gives a few tenths of a percent better efficiencies and a much better cost of ownership. So compared to most of the large in-line tools, that is the advantage. That's also why we moved away from the in-line towards this tube-type batch. And the tube-type batch is--the advantage that--like with most batch systems you can do--you have time to do different things. You don't have to take very quickly just one layer, but you can do more than that. So it's--we see it also very important for the future, too, to have the anti-reflection layers that do not have pin holes and that can be important for future steps when they come, for example, with (inaudible - accented). And we see good possibilities with process development, which we deal with the energy research center, as you know, to get just better efficiencies, even more than we see today.

Okay. And a couple for--thank you for that. And a couple for Brad. Brad, the gross margin guidance, does that include the $1.9 million inventory charge? So when you--are you looking at an apples-to-apples comparison of gross margins versus this most recent quarter? Should we back that out or not? Do you have additional inventory charges coming up in the upcoming quarter?

We--the guidance is really comparing the GAAP gross margin, which was 19%, to what we expect, which we expect it to be in line or even--or higher than that.

Okay.

So as far as future write-downs, I mean, of course, you take your best estimate based on what you know at the end of each quarter and we can--we've done that in the past and we'll continue to do that. But I think we took what we believe to be the appropriate write-down and reserve on inventory.

And was that raw material inventory or [whip] or finished goods?

Well, primarily--no, primarily parts--what we call parts/raw materials.

Okay. And then, Colin asked about the R&D side, which was understandable if you build a second Beta or not. Can you talk about what your expectations are for SG&A in the second half?

Well, let's split that just a little bit. On the S-side, those costs tend to be--a substantial portion of it tend to be variable because we still have a commission based sales force. We also look at--as we mentioned in our prepared remarks--shipping costs are variable compared to the volume. So we see that continuing to be managed just fine. And we'll look at the other parts of selling, whether it's trade show and related travel costs. We continue to evaluate that. On the G&A side, trend wise we continue to look at incremental steps to reduce those costs, but I would say overall we took a lot of steps early on in the process back in I'd say almost towards the end of our last fiscal year. But trend wise, don't see really significant changes.

All right, perfect. I wasn't sure with [any of] your products if you were going to step on the gas there a little bit. But two other ones quickly for Fokko. Can you give us a sense of the orders within solar, what--the profile of the type of customer that is buying in this type of environment? Are they Taiwanese, Korean, Chinese state-owned enterprises? That was question one. And then, question two is in particular with the semi strength sequentially, do you have a sense of which end market that was going to?

Okay. First, the question about what sort of customer is buying. And let's say it this way - the ones that are less directly subjected to the pricing pressure in the markets are the ones that have the highest chance. So that would fall in that last category of the alternative you gave. Some of them have their own markets, so that makes it a little bit easier. And on the semi side, yes, we do know which type of product it is - that's more the analog. And we also have good hope that will continue for some time. Of course, it's also--the semi is up and down and we don't have a very large number of customers. But so far, that looks good and it's all on the analog side.

Okay. Thanks much.

Thanks, Jeff.

(Operator Instructions) The next question comes from Howard Halpern of Taglich Brothers. Please go ahead.

Good afternoon. Just I guess want to get maybe a sense of the big picture down the road when things start to turn up. What do you envision the ion implant market to be say two years down the road, and the LED--and the prospects for the LED market and getting into that, and what does that look like for the future?

Okay, first, down the road two years from now in ion implant. And of course, there are analysts that give numbers like that, but our expectation is that two years from now--two or three years from now the numbers will be worldwide. Well, what's the number - 40, 50, in that range that is expected. That market is about $50 million to $100 million. And--but things could go quicker and we see a lot of interest in ion implant and of course, it also depends on how successful that goes into production. So far, cost of ownerships have always been high and that holds it back a little bit. And we hope that we can prove that the [COO] of the [project] is better, so that could also accelerate it quite a bit. So that is also partly dependent on our own success how quickly a product like this could be set in production in large volumes.

And in LED--we have limited activity in LED and we're looking at ways to broaden that, but to give an estimate on how much that could give in the near future, I wouldn't be able to give it at this moment.

Okay. Are there any other besides the LED that you're starting to inquire, so you investigate actually to look at to broaden the portfolio of products in the industries that you serve?

Say within the existing operations--we don't plan to be outside the semiconductor and solar in LED. Of course, semiconductor is something where in times when solar is booming you have less time, so it means that we put a lot more emphasis on getting more business out of the semiconductor. So that's where on the short term I would see from the existing operations the--a bit of growth going.

Okay, thanks.

The next question comes from Gordon Johnson of Axiom Capital Management. Please go ahead.

Thanks for taking my question. Good evening, gentlemen. I'm just looking--I'm looking at your cash flow here or I guess not your cash flow, but your cash balance. I noticed it declined again sequentially. And just looking at your days of inventory and your days sales outstanding, it looks like you have over six months of days in inventory and over four months of days sales outstanding. Is it possible--I noticed this question was I guess broached before, but is it possible that we could see incremental inventory and potentially receivables right now if the market doesn't improve?

I'll take that. I mean, there's--are there always possibilities? There's always possibilities. I think we took--I think a healthy look at both inventory--and we always are evaluating our receivables. And I think we've got them adequately stated at this time and we continue to--no, you look at our backlog, which we have, and then you compare that to what we've got in inventory and it's not--we're not in really too bad a shape there. So, yes, do days--DSOs start to stretch out? Sure. I mean, in this kind of environment, I think that's expected with your customers and you continue to work with them. And--but we believe what we've recorded on the books and the reserves that we have are appropriate and adequate at this time.

Okay. And then, with respect to the cash balance, how do you guys see cash trending beyond this quarter, or maybe into next quarter and next year? Will we start to see that cash balance start to improve, or as long as the market remains weak will we start to see it continue to trickle lower?

We haven't given any public comment on future cash, but of course, our objectives are to manage our inventory, get that--see that start to turnaround in the coming quarters and start reducing our inventory. But with your--when you're at lower shipment levels, that takes a little bit more time. But we continue to work on that and that is our objective and goal is to continue to manage the working capital to right size it to existing realities in the marketplace today and in the near future.

That's helpful. And then, just one more. If you could let us know what your utilization rate was this quarter and also kind of what you expect it to be next quarter, maybe even if you could, what you envision it being next year. Thanks a lot, guys.

Thanks, Gordon. From a utilization standpoint, of course, we're underutilized with our facility. I mean, we were--a year ago we were doing--we did $70 million in a quarter, a little over--less than a year ago. So downsizing and we've done a lot there. Fokko spoke to that. Our solar related divisions are down over 40% from a headcount standpoint. But we don't give any specific factory utilization rates, but obviously we're substantially lower on utilization rates than we were three quarter--two, three quarters ago.

And can you give some guidance on kind of how we should expect that to trend maybe this year, and if you could, some incremental guidance on next year as well.

Well, for--from our remarks that we've made on the future, I think we've said that the market looks still low demand scenario in the near term and we continue to manage that. And we'll--as we get into fiscal 2013 and calendar year '13, we'll obviously look at that and have a little more clarity as we get a little bit closer to that timeframe.

Okay, thanks, again.

Thanks, Gordon.

(Operator Instructions) The next question comes from David Dansby of Janney Montgomery Scott. Please go ahead.

Hi, gentlemen. I was just calling kind of to get back on the solar order front. Every week it seems like we see panel manufacturers reducing capacity, shuttering plants. But I did notice one of your larger customers has made plans to expand new capacity by roughly 40% in 2012, or 650 megawatts. And I was just comment--I was just wondering if you all have heard or seen anything related to this.

Yes, we've heard about it and it does not necessarily mean that we are fully involved in that. It is a potential, but not something where--that is--we're talking about the same person as we--that you think. It is not for the new technology. It is for the older technology expansions. So, yes, we know about it, but that's all I can say.

Thank you.

Thanks, David.

This concludes our question and answer session. I would like to turn the conference back over to Brad Anderson for any closing remarks.

Thank you for joining us today. We look forward to reporting to you again on our progress, and appreciate your continued interest in Amtech. I will be available for any questions you may have and welcome your follow-up calls. This concludes today's call. Thank you.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.